Trial intelligence / Profile preview

Gelatine vs 5% human albumin preloading during Kasai portoenterostomy in biliary atresia

ChiCTR2300071162Phase 4Not yet recruiting

Sponsor
The First Affiliated Hospital of Sun Yat-sen University
Start
Jun 2022
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial in biliary atresia comparing Artificial colloid (succinylated gelatine) preloading with Human albumin 5% preloading (control) (2 arms). Primary endpoint: thromboelastography parameters. Planned start Jun 2022; status: not yet recruiting.

02

Drugs

succinylated gelatinalbumin (human)
03

Conditions

biliary atresia

Beyond the preview

Go deeper on ChiCTR2300071162.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300071162.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call